Dexmedetomidine does not produce vasocontraction on human isolated gastroepiploic artery

Korean Journal of Anesthesiology

Volumn 60, Issue 6, 2011, Pages 428-433

  Kim, Won Sung ^a,b   Baek, Seung Hoon ^a,b   Lee, Sang Kwon ^b,c   Jeon, Tae Yong ^b,d   Kim, Hee Young ^a,b   Shin, Sang Wook ^a,b  

^a Pusan National University Yangsan Hospital   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

^c Departments of Toracic and Cardiovascular Surgery   (South Korea)

^d Pusan National University School of Medicine   (South Korea)

Author keywords

Coronary artery bypass surgery; Dexmedetomidine; Gastroepiploic artery; Vasopressin

Indexed keywords

DEXMEDETOMIDINE; VASOPRESSIN;

ADULT; AGED; ARTERY CONSTRICTION; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CORONARY ARTERY BYPASS SURGERY; DRUG BLOOD LEVEL; DRUG POTENTIATION; GASTRECTOMY; GASTROEPIPLOIC ARTERY; HUMAN; HUMAN TISSUE; TISSUE; VASOCONSTRICTION;

EID: 79959823063     PISSN: 20056419     EISSN: 20057563     Source Type: Journal    
DOI: 10.4097/kjae.2011.60.6.428     Document Type: Article

References (15)

1. Gomes WJ, Carvalho AC, Palma JH, Teles CA, Branco JN, Silas MG, et al. Vasoplegic syndrome after open heart surgery. J Cardiovasc Surg (Torino) 1998; 39: 619-23.
2. Dünser MW, Mayr AJ, Ulmer H, Ritsch N, Knotzer H, Pajk W, et al. The effects of vasopressin on systemic hemodynamics in catechola-mine-resistant septic and postcardiotomy shock: a retrospective analysis. Anesth Analg 2001; 93: 7-13.
3. Masetti P, Murphy SF, Kouchoukos NT. Vasopressin therapy for vasoplegic syndrome following cardiopulmonary bypass. J Card Surg 2002; 17: 485-9.
4. Morales DL, Garrido MJ, Madigan JD, Helman DN, Faber J, Williams MR, et al. A double-blind randomized trial: prophylactic vaso-pressin reduces hypotension after cardiopulmonary bypass. Ann Torac Surg 2003; 75: 926-30.
5. Wei W, Floten HS, He GW. Interaction between vasodilators and vasopressin in internal mammary artery and clinical significance. Ann Torac Surg 2002; 73: 516-22.
6. Wei W, Yang CQ, Furnary A, He GW. Greater vasopressin-induced vasoconstriction and inferior effects of nitrovasodilators and milrinone in the radial artery than in the internal thoracic artery. J Torac Cardiovasc Surg 2005; 129: 33-40.
7. Talke P, Lobo E, Brown R. Systemically administered alpha2-agonist-induced peripheral vasoconstriction in humans. Anesthe-siology 2003; 99: 65-70.
8. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000; 93: 382-94.
9. Link RE, Desai K, Hein L, Stevens ME, Chruscinski A, Bernstein D, et al. Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and c. Science 1996; 273: 803-5.
10. Hamasaki J, Tsuneyoshi I, Katai R, Hidaka T, Boyle WA, Kanmura Y. Dual alpha(2)-adrenergic agonist and alpha(1)-adrenergic antagonist actions of dexmedetomidine on human isolated endothelium-denuded gastroepiploic arteries. Anesth Analg 2002; 94: 1434-40.
11. Coughlan MG, Lee JG, Bosnjak ZJ, Schmeling WT, Kampine JP, Warltier DC. Direct coronary and cerebral vascular responses to dexmedetomidine. Significance of endogenous nitric oxide synthesis. Anesthesiology 1992; 77: 998-1006.
12. Yildiz O, Ulusoy HB, Seyrek M, Gul H, Yildirim V. Dexmedetomidine produces dual alpha2-adrenergic agonist and alpha1-adrenergic antagonist actions on human isolated internal mammary artery. J Cardiothorac Vasc Anesth 2007; 21: 696-700.
13. Nielsen H, Mortensen FV, Pilegaard HK, Hasenkam JM, Mulvany MJ. Calcium utilization coupled to stimulation of postjunctional alpha-1 and alpha-2 adrenoceptors in isolated human resistance arteries. J Pharmacol Exp Ter 1992; 260: 637-43.
14. Henderson KK, Byron KL. Vasopressin-induced vasoconstriction: two concentration-dependent signaling pathways. J Appl Physiol 2007; 102: 1402-9.
15. He GW, Yang CQ. Comparison among arterial grafts and coronary artery. An attempt at functional classification. J Torac Cardiovasc Surg 1995; 109: 707-15.